Lasik Xtra®

Lasik Xtra®
enhancing the power of LASIK
®
Avedro’s cross-linking systems and family of riboflavin products are not for sale in the US.
Seamlessly Integrated Into Your LASIK Procedure
Since 2010, Avedro has been on the forefront
of developing corneal cross-linking with
LASIK. Avedro offers you the experience and
confidence to enhance your practice,
and take even better care of your patients.
Performed in conjunction with LASIK,
Avedro’s Lasik Xtra procedure enhances
the cornea’s biomechanical integrity—
reducing the amount of refractive regression.
The goal of Lasik Xtra is to help
achieve more stable, predictable
visual outcomes by enhancing
the biomechanical integrity of the
cornea after LASIK surgery to:
• Decrease the amount of
regression over time1
• Increase refractive accuracy2
Scientific Development
The KXL System is CE
Marked and not available
for sale in the US.
Avedro’s riboflavin formulations are CE Marked
and have been carefully developed by our
scientists, ensuring optimal customization for
your LASIK, PRK or SMILE procedure.
Improved Stability in Hyperopic
LASIK Patients at 2 Years 1
60%
0.4
50%
0.5
0.5
40%
0.6
0.6
30%
0.7
0.7
0.72
10%
0.9
0.8
20%
0.8
0.9
+/- 0.50
+/- 1.00
LASIK Only
90%
90%
98%
98%
84%
84%
65%
65%
60%
60%
50%
50%
40%
40%
30%
30%
20%
20%
10%
10%
0%
0%
+/+/-0.50
0.50
1
0%1
70%
70%
0.4
Change in Mean Keratometry (D)
65% 0.22
80%
80%
0.3
70%
0.3
90%
90%
0.2
84%
80%
0.2
100%
LA…100%
0.1
90%
0.1
98%
90%
0
100%
0
Greater Refractive Accuracy in High
Myopic LASIK Patients at 3 Months2
+/1.00
+/- 1.00
LASIK with Lasik Xtra
Who May Benefit from Lasik Xtra?
•
Highly Myopic Patients
•
Hyperopic Patients
•
Young patients
•
Borderline residual bed thickness patients
•
Patients with a family history of keratoconus
•
All LASIK Patients
How Can Lasik Xtra Work in Your Practice?
Benefits to Practice
• New revenue stream—widely
demonstrated patient acceptance
of premium pricing
• Practice differentiation—innovative
corneal cross-linking technology
• Only 3 minutes of additional
procedure time
Benefits to Patient
• Peace of mind—highest quality
eye care possible
• Reduction in risk of refractive
regression
• Improved outcomes and lower
retreatment rates
LA
What the Experts are Saying:
“
“Having been the first corneal surgeon to perform laser refractive surgery
in Canada over 20 years ago, I have seen many innovations, and believe
Lasik Xtra to be one of the simplest to perform and most beneficial to
my LASIK patients.”
— Howard Gimbel, MD
Gimbel Eye Centre, Canada
“As one of the earliest adopters of Lasik Xtra, the procedure has not only
helped to elevate my practice profile and increase its revenue, but also
provide peace of mind for patients who may have otherwise been on
the fence in deciding to get LASIK.”
— Jerry Tan, MD
Jerry Tan Por Yong Ming Eye Surgery, Singapore
“The Lasik Xtra procedure has proven to be a valuable asset to my
practice for LASIK, PRK and SMILE patients alike. The fact that I can
use state-of-the-art cross-linking technology in conjunction with each of
these refractive procedures helps me to take my practice and my patient
care to the next level.”
— Pavel Stodulka, PhD
”
Gemini Eye Clinic, Czech Republic
Avedro is a privately held medical device and pharmaceutical company
advancing the science and technology of corneal cross-linking.
Over 100,000 Treatments Performed with the KXL System Across the Globe
KXL Systems
*Investigational Use Only in the US
| Medical Advisory Board
John Berdahl, MD
William J. Dupps, Jr., MD, PhD
Daniel Durrie, MD
Michael Gordon, MD
Peter S. Hersh, MD, FACS
A. John Kanellopoulos, MD
John Marshall, MBE, PhD
Michael B. Raizman, MD
Rajesh K. Rajpal, MD
Roger F. Steinert, MD
Vance Thompson, MD, FACS
Stephen L. Trokel, MD
George O. Waring IV, MD FACS
781.768.3400 | [email protected] | www.avedro.com
Avedro’s cross-linking systems and family of riboflavin products are not for sale in the US.
MA-00341B
Kanellopoulos AJ, Kahn J. Topography-guided Hyperopic LASIK With and Without High Irradiance Collagen Cross-linking:
Initial Comparative Clinical Findings in a Contralateral Eye Study of 34 Consecutive Patients. Journal of Refractive Surgery. 2012
November; 28(11): S837-S840.
1
Tan J, Por Y. 1 year experience with corneal wavefront-guided LASIK with flash cross-linking (LASIK Xtra) for the treatment of
high myopia patients (-8.00D to -18.00D) using the SCHWIND Amaris 750S laser: clinical outcomes. Paper presented at: XXXI
Congress of the European Society of Cataract and Refractive Surgeons; 2013 Oct 5-9; Amsterdam, Netherlands.
2